Investigators hired by the board of eFishery have determined the Indonesian start-up is in far worse shape than they previously thought, and that investors are likely to get back less than 10 US ...

By 2030, OpenAI expects to get three-quarters of its data center capacity from Stargate, a project that’s expected to be heavily financed by SoftBank, one of OpenAI’s newest financial backers.

Patients with a dual diagnosis, ie an active addiction and a mental health challenge, often find they fall between the cracks of both mental health services and addiction services. Previous ...

TOKYO -- SoftBank Group Chairman and CEO Masayoshi Son was in his element when he took the stage in Tokyo this month to lay out his vision for artificial intelligence. Holding a crystal ball in ...

Chinese researchers from the Tianjin University (TJU) and Tsinghua University have collaborated to develop the world's first "dual-loop" non-invasive brain-computer interface (BCI) system ...

Sam Altman and board members are evaluating new governance measures The move could help OpenAI block future hostile takeover attempts On Friday, OpenAI rejected a $97.4 billion acquisition bid led by ...

Nissan Motor Co.’s credit-default swaps widened to the most among Japanese companies, overtaking both Rakuten Group Inc. and SoftBank Group Corp. after its consolidation talks with Honda Motor ...

What’s a dual fuel tariff? A dual fuel tariff means your gas and electricity comes from the same provider. You get just 1 energy bill and 1 point of contact. It’s a potentially economical and ...

Setting up a dual SIM on your Samsung Galaxy can maximize connectivity, but small mistakes may lead to network issues and misrouted calls or messages. This tutorial outlines several common ...

The Japanese investment holding company SoftBank Group (OTCPK:SFTBY) purchased two new stakes: 20.45M shares in Pacific Biosciences of California (PACB), and 14.66M shares in Recursion ...

SoftBank disclosed a 20.45M share position in PacBio (PACB) and 14.67M share position in Recursion Pharmaceuticals (RXRX) in a regulatory filing detailing its holdings as of December 31, 2024 ...